Yao Jinna, Tse Vincent
Department of Surgery, Macquarie University Hospital, Sydney, Australia.
Concord Repatriation General Hospital, Sydney, Australia.
Int Neurourol J. 2022 Jun;26(2):102-110. doi: 10.5213/inj.2142086.043. Epub 2022 Jun 30.
Midurethral slings (MUS) are widely accepted for the surgical treatment of stress urinary incontinence (SUI) in cases where conservative treatment has failed. They have been shown to be a safe and effective surgical treatment for the management of SUI. However, there have recently been growing concerns regarding the safety profile of mesh procedures, generating international debate and leading to national inquiries into the effectiveness and safety of mesh implants. A multitude of clinical, technical, manufacturer-related, and other health jurisdictional factors are involved in the outcomes of MUS. Appropriate patient selection and informed consent to all treatment options, with proper guidance from healthcare providers, are critical for empowering women to choose an appropriate treatment option based on a personalized decision.
对于保守治疗失败的压力性尿失禁(SUI)病例,中段尿道吊带术(MUS)已被广泛认可用于手术治疗。它们已被证明是治疗SUI的一种安全有效的手术方法。然而,最近人们对网状手术的安全性越来越关注,引发了国际辩论,并导致各国对网状植入物的有效性和安全性进行调查。MUS的结果涉及众多临床、技术、制造商相关以及其他卫生管辖因素。在医疗服务提供者的适当指导下,进行适当的患者选择并对所有治疗方案给予充分知情同意,对于使女性能够基于个性化决策选择合适的治疗方案至关重要。